We explored the acute effects on arterial blood gases and spirometry of two doses of indacaterol Breezhaler ( 150 and 300g ) in 12 patients hospitalised because of an AECOPD in 2 non-consecutive days under open-label , randomized , crossover conditions , with blind evaluation .